Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Merpuls AB
AB
Active
Org 5590320114
Hornsgatan 151
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2015
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 57K
-80% vs 2023
EBITDA margin
-29.0%
-125% vs 2023
Equity ratio
74.0%
Financial strength
Net profit 2024
SEK -16K
-133% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 57K
-80%
EBITDA
SEK -17K
-125%
Net profit
SEK -16K
-133%
Total assets
SEK 114K
-46%
Equity
SEK 84K
-16%
Employees
0
—
Company information
Legal name
Merpuls AB
Org number
5590320114
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26 oktober 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget kommer att bedriva utbildning och föreläsa inom området hjärt och lungräddning, samt försälja produkter och tjänster kopplade till området.
Contact
Address
Hornsgatan 151
Email
info@merpuls.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
114
150
234
290
57
Staff expenses
—
—
−15
−18
−6
EBITDA
−53
46
56
66
−17
Depreciation & amort.
−2
−0
—
—
—
EBIT
−55
46
56
66
−17
Net financials
—
—
0
0
0
Profit before tax
−56
45
56
67
−16
Tax
−0
−0
−14
−18
—
Net profit
−56
45
42
49
−16
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
50
181
219
211
114
Equity
−6
40
81
100
84
Long-term debt
0
0
—
—
—
Short-term debt
55
141
138
111
30
Total debt
55
141
138
111
30
Financial ratios
5-year trend
EBITDA margin
-29.0%
This company
15.8%
Market median
-284% vs market
2020
2024
Equity ratio
74.0%
This company
38.2%
Market median
+94% vs market
2020
2024
Return on equity
-19.5%
This company
18.4%
Market median
-206% vs market
2020
2024
Net profit margin
-28.7%
This company
8.1%
Market median
-454% vs market
2020
2024
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
2020
2024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
CD
Claes Daniel Del Valle Källberg
Deputy Board Member
2022
DG
Daniel Gilberto Gallo-Marchiando
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Merpuls AB also hold positions in
0
other companies.
Person
Role here
Other companies
Claes Daniel Del Valle Källberg
Deputy Board Member
0 companies
Daniel Gilberto Gallo-Marchiando
Board of Directors
0 companies